Impact of Hospital Procedural Volume on Outcomes Following Balloon Aortic Valvuloplasty
Balloon aortic valvuloplasty (BAV) is indicated in patients with acute decompensated heart failure or cardiogenic shock secondary to severe aortic stenosis,1 either as palliative therapy for patients who are not candidates for valve replacement,2 or as a bridge to transcatheter (TAVR) or surgical aortic valve replacement (SAVR).1,3 Given the high morbidity and mortality associated with BAV, especially because it is performed not infrequently in critically ill patients, it is important to understand the effect of hospital procedural volume on outcomes following BAV.
Source: The American Journal of Cardiology - Category: Cardiology Authors: Agam Bansal, Vardhmaan Jain, Ashish Kumar, Shashank Shekhar, Grant W. Reed, Amar Krishnaswamy, Serge C. Harb, Ankur Kalra, Rishi Puri, Samir R. Kapadia Source Type: research
More News: Aortic Stenosis | Cardiogenic Shock | Cardiology | Grants | Heart | Heart Failure | Heart Valve Surgery | Hospitals | Palliative